34.340 0.62%

The Lancet Oncology - Journal Impact

The Journal Impact 2019-2020 of The Lancet Oncology is 34.340, which is just updated in 2020. Compared with historical Journal Impact data, the Factor 2019 of The Lancet Oncology grew by 0.62% . The Journal Impact Quartile of The Lancet Oncology is Q1. The Journal Impact of an academic journal is a scientometric factor that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a factor for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The Journal Impact measures the average number of citations received in a particular year (2019) by papers published in the journal during the two preceding years (2017-2018). Note that 2019 Journal Impact are reported in 2020; they cannot be calculated until all of the 2019 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of The Lancet Oncology.


The Lancet Oncology Real-Time Journal Impact/Jouranl Factor Prediction & Tracking, 2020 2019 2018 2017 2016 2015 Journal Impact | Factor Trend & History - Academic Accelerator


The Lancet Oncology - Journal Impact Prediction System

Journal Impact Prediction System provides an open, transparent, and straightforward platform to help academic researchers Predict future factor and performance through the wisdom of crowds. Journal Impact Prediction System displays the exact community-driven factor without secret algorithms, hidden factors, or systematic delay.

The Lancet Oncology Journal Impact Prediction System - Factor and Trend
  • Article Volume 2017 624
  • Article Volume 2016 646
  • Article Volume 2015 639
  • ISSN
  • 14702045, 14745488
  • Open Access
  • Publisher
  • The Lancet Publishing Group
  • Country/Region
  • United Kingdom
  • History
  • Categories
  • Oncology (Q1)

The Lancet Oncology - ISSN

The ISSN of The Lancet Oncology is 14702045, 14745488. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

The Lancet Oncology - ISSN

The Lancet Oncology - Subscription (non-OA) Journal

The Lancet Oncology is a Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

The Lancet Oncology - Open Access

The Lancet Oncology - Publisher

The Lancet Oncology is published by The Lancet Publishing Group, which is located in the United Kingdom. The Publication History of The Lancet Oncology covers 2000-ongoing.

The Lancet Oncology - Publisher

The Lancet Oncology - Categories

The Lancet Oncology is a peer-reviewed scientific journal. The scope of The Lancet Oncology covers Oncology (Q1).

The Lancet Oncology - Categories

The Lancet Oncology - Journal Factors

It is impossible to get a true picture of impact using a single factor alone, so a basket of factors is needed to support informed decisions. In addition to Abbreviation, Acceptance Rate, Review Speed, Research Hotspot and Template, several advanced Journal Factors including Citescore, H-Index, Self-Citation Ratio, SJR (SCImago Journal Rank Indicator) and SNIP (Source Normalized Impact per Paper) can provide you comprehensive insights into the The Lancet Oncology.

The Lancet Oncology - Journal Metrics

Journal Ranking